Bio-Gene Technology Limited reported significant progress in its bio-insecticide development, including OMRI approval for Qcide and promising efficacy data for Flavocide, while managing a $1.4 million loss in H1 2026.
Bio-Gene Technology reports significant progress in developing its bio-insecticides Flavocide and Qcide, including new efficacy data and organic certification, positioning the company for growth amid rising global demand for safer pest control.